chr4-3493359-C-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_173660.5(DOK7):​c.1373C>A​(p.Ala458Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000067 in 1,596,390 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A458V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000066 ( 0 hom. )

Consequence

DOK7
NM_173660.5 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 2.60

Publications

0 publications found
Variant links:
Genes affected
DOK7 (HGNC:26594): (docking protein 7) The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
DOK7 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 10
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • fetal akinesia deformation sequence 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08495441).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DOK7NM_173660.5 linkc.1373C>A p.Ala458Asp missense_variant Exon 7 of 7 ENST00000340083.6 NP_775931.3 Q18PE1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DOK7ENST00000340083.6 linkc.1373C>A p.Ala458Asp missense_variant Exon 7 of 7 1 NM_173660.5 ENSP00000344432.5 Q18PE1-1
DOK7ENST00000643608.1 linkc.941C>A p.Ala314Asp missense_variant Exon 5 of 8 ENSP00000495701.1 A0A2R8Y701
DOK7ENST00000515886.5 linkc.443C>A p.Ala148Asp missense_variant Exon 4 of 4 2 ENSP00000492194.1 A0A1W2PRA3
DOK7ENST00000507039.5 linkc.*594C>A 3_prime_UTR_variant Exon 7 of 7 2 ENSP00000423614.1 Q18PE1-4

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152198
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000910
AC:
19
AN:
208716
AF XY:
0.000113
show subpopulations
Gnomad AFR exome
AF:
0.0000856
Gnomad AMR exome
AF:
0.000256
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000903
Gnomad OTH exome
AF:
0.000385
GnomAD4 exome
AF:
0.0000665
AC:
96
AN:
1444192
Hom.:
0
Cov.:
95
AF XY:
0.0000725
AC XY:
52
AN XY:
716792
show subpopulations
African (AFR)
AF:
0.0000906
AC:
3
AN:
33114
American (AMR)
AF:
0.000259
AC:
11
AN:
42482
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25616
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39026
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84510
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50376
Middle Eastern (MID)
AF:
0.000701
AC:
4
AN:
5706
European-Non Finnish (NFE)
AF:
0.0000580
AC:
64
AN:
1103844
Other (OTH)
AF:
0.000235
AC:
14
AN:
59518
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000723
AC:
11
AN:
152198
Hom.:
0
Cov.:
34
AF XY:
0.0000538
AC XY:
4
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41430
American (AMR)
AF:
0.000131
AC:
2
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68030
Other (OTH)
AF:
0.000478
AC:
1
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000284
Hom.:
0
Bravo
AF:
0.0000907
ExAC
AF:
0.0000680
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Sep 10, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1373C>A (p.A458D) alteration is located in exon 7 (coding exon 7) of the DOK7 gene. This alteration results from a C to A substitution at nucleotide position 1373, causing the alanine (A) at amino acid position 458 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Congenital myasthenic syndrome 10 Uncertain:1
Dec 23, 2018
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Fetal akinesia deformation sequence 1;C1850792:Congenital myasthenic syndrome 10 Uncertain:1
Jul 19, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 458 of the DOK7 protein (p.Ala458Asp). This variant is present in population databases (rs778440478, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with DOK7-related conditions. ClinVar contains an entry for this variant (Variation ID: 565957). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Jun 24, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
15
DANN
Benign
0.28
DEOGEN2
Benign
0.080
T;.;.
Eigen
Benign
-0.94
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.42
T;T;T
M_CAP
Uncertain
0.091
D
MetaRNN
Benign
0.085
T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.8
L;.;.
PhyloP100
2.6
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.6
N;.;.
REVEL
Benign
0.092
Sift
Uncertain
0.029
D;.;.
Sift4G
Benign
0.16
T;.;.
Polyphen
0.18
B;.;.
Vest4
0.16
MutPred
0.28
Loss of MoRF binding (P = 0.049);.;.;
MVP
0.28
MPC
0.0065
ClinPred
0.065
T
GERP RS
0.90
Varity_R
0.17
gMVP
0.088
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs778440478; hg19: chr4-3495086; API